Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Raw Materials: 2017-2024

Historic Raw Materials for China Pharma Holdings (CPHI) over the last 7 years, with Sep 2024 value amounting to $869,820.

  • China Pharma Holdings' Raw Materials fell 53.69% to $869,820 in Q3 2024 from the same period last year, while for Sep 2024 it was $869,820, marking a year-over-year decrease of 53.69%. This contributed to the annual value of $1.8 million for FY2023, which is 0.52% up from last year.
  • Per China Pharma Holdings' latest filing, its Raw Materials stood at $869,820 for Q3 2024, which was down 27.15% from $1.2 million recorded in Q2 2024.
  • In the past 5 years, China Pharma Holdings' Raw Materials registered a high of $2.2 million during Q1 2023, and its lowest value of $869,820 during Q3 2024.
  • Moreover, its 3-year median value for Raw Materials was $1.8 million (2022), whereas its average is $1.7 million.
  • Per our database at Business Quant, China Pharma Holdings' Raw Materials grew by 20.50% in 2023 and then crashed by 53.69% in 2024.
  • Over the past 5 years, China Pharma Holdings' Raw Materials (Quarterly) stood at $2.1 million in 2020, then declined by 11.63% to $1.8 million in 2021, then remained steady at $1.8 million in 2022, then climbed by 0.52% to $1.8 million in 2023, then tumbled by 53.69% to $869,820 in 2024.
  • Its last three reported values are $869,820 in Q3 2024, $1.2 million for Q2 2024, and $1.7 million during Q1 2024.